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vps33 mutants missort and secrete multiple vacuolar hydrolases and exhibit extreme defects in vacuolar
morphology. Toward a molecular understanding of the role of the VPS33 gene in vacuole biogenesis, we have
cloned this gene from a yeast genomic library by complementation of a temperature-sensitive vps33 mutation.
Gene disruption demonstrated that VPS33 was not essential but was required for growth at high temperatures.
At the permissive temperature, vps33 null mutants exhibited defects in vacuolar protein localization and
vacuole morphology similar to those seen in most of the original mutant alleles. Sequence analysis revealed a
putative open reading frame sufficient to encode a protein of 691 amino acids. Hydropathy analysis indicated
that the deduced product of the VPS33 gene is generally hydrophilic, contains no obvious signal sequence or
transmembrane domains, and is therefore unlikely to enter the secretory pathway. Polyclonal antisera raised
against TrpE-Vps33 fusion proteins recognized a protein in yeast cells of the expected molecular weight,
-75,000. In cell fractionation studies, Vps33p behaved as a cytosolic protein. The predicted VPS33 gene
product possessed sequence similarity with a number of ATPases and ATP-binding proteins specifically in their
ATP-binding domains. One vps33 temperature-sensitive mutant contained a missense mutation near this region
of sequence similarity; the mutation resulted in a Leu-646 -* Pro substitution in Vps33p. This temperature-
sensitive mutant strain contained normal vacuoles at the permissive temperature but lacked vacuoles
specifically in the bud at the nonpermissive temperature. Our data suggest that Vps33p acts in the cytoplasm
to facilitate Golgi-to-vacuole protein delivery. We propose that as a consequence of the vps33 protein-sorting
defects, abnormalities in vacuolar morphology and vacuole assembly result.
Eucaryotic cells contain a number of distinct membrane-
enclosed organelles whose function and morphology are
defined largely by the unique set of proteins residing within
them. Thus, mutations that disrupt the accurate sorting of
proteins to their correct intracellular locations might also
affect the assembly and morphology of the target organelle.
Conversely, abnormalities in organelle biogenesis may be
manifest as protein trafficking or delivery defects.
In the yeast Saccharomyces cerevisiae, proteins destined
for the lysosomelike vacuole traverse the secretory pathway
en route to the vacuole. Soluble vacuolar proteins such as
carboxypeptidase Y (CPY) and proteinase A (PrA) are
synthesized as inactive precursors; upon delivery to the
vacuole, these proenzymes undergo proteolytic processing
to generate the mature active enzymes (14, 15, 26, 49). We
and others have recently isolated a number of mutants that
exhibit defects in the proper localization and processing of
multiple vacuolar hydrolases (1, 40, 42, 43). These vacuolar
protein sorting, or vps, mutants define more than 40 com-
plementation groups. Morphological studies using both light
and electron microscopy have revealed at least three distinct
groups of vps mutants (2). The majority of the vps mutants
(called class A vps mutants) contain morphologically wild-
type (wt) vacuoles. A second class of mutants, class B, is
characterized by an altered morphology in which the vacuole
is highly fragmented. Mutants in four vps complementation
groups exhibit the most extreme abnormalities in vacuole
morphology. Electron microscopic analysis has revealed
that these cells accumulate many small vesicles but lack any
compartment that resembles a wt vacuole. This morphology
has been designated class C (2).
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The class C vps mutants exhibit extreme defects in the
sorting and processing of soluble vacuolar proteins. In these
strains, the Golgi-modified forms of CPY, PrA, and protein-
ase B accumulate and are secreted. Little or no mature forms
of these vacuolar enzymes can be detected in these mutants.
Unlike other vps mutants, these class C strains also mislo-
calize as much as 50% of the activity of a vacuolar mem-
brane enzyme, a-mannosidase (40). The class C vps mutants
exhibit other genetically linked phenotypic defects, includ-
ing temperature-sensitive (Ts) growth and sensitivity to
osmotic stress. However, nonvacuolar functions such as
secretion and microtubule assembly, as well as nuclear and
mitochondrial structure, appear to be unaffected in these
strains (2, 40).
In an effort to understand the molecular basis for the
phenotypic defects exhibited by the class C vps mutants, we
have examined in more detail the seven mutants comprising
one of these class C complementation groups, vps33. We
report here the cloning of the VPS33 gene. This gene is not
essential but is required for growth at 37°C. The predicted
VPS33 gene product is a relatively hydrophilic protein of
-75 kilodaltons (kDa) that shares sequence similarity with a
number of ATP-binding proteins. Cell fractionation studies
indicate that Vps33p is soluble. We suggest that the VPS33
gene product acts in the cytoplasm to facilitate Golgi-to-
vacuole trafficking, thereby promoting vacuole assembly.
MATERIALS AND METHODS
Strains and media. Escherichia coli MC1061 [F- araDJ39
A(araABOIC-leu)7679 AlacX74 galU galK rpsL hsdR strA]
(4), JM101 [supE thi A(lac-proAB) (F' traD36 proAB lacIq Z
M15)] (27), and DH1 [F- endAl hsdR17 (rK- mK+) supE44
thi-J recAl gyrA96 relAl?] (13) were used for cloning and
TrpE-Vps33 fusion protein production. E. coli JF1754 (hsdR
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metB leuB hisB lac gal) (25) was used in screening plasmids
pLB33-313 and pLB33-317. S. cerevisiae parental strains
were SEY6210 (MAToL ura3-52 leu2-3,112 his3-A200 trpl-
A901 lys2-801 suc2-A9) and SEY6211 (MATa ura3-52 leu2-
3,112 his3-A200 trpl-A901 ade2-101 suc2-A9) (40). vps33
mutant strains SEY33-2, SEY33-4, and SEY33-5 are iso-
genic with SEY6210 and carry the vps33-2, vps334, and
vps33-5 mutations, respectively. SEY33-7, carrying the
vps33-7 allele, is isogenic with SEY6211. LBY317 carries a
vps33 null mutation and was derived from SEY6210 (see
below). Bacterial strains were grown on standard media (28).
Yeast strains were grown on standard yeast extract-peptone-
dextrose (YPD) or synthetic dextrose (SD) (synthetic mini-
mal, supplemented as necessary) medium (47).
Materials. Restriction enzymes, T4 DNA ligase, Klenow
enzyme, and polyacrylamide gel electrophoresis supplies
were purchased from Boehringer Mannheim Biochemicals
(Indianapolis, Ind.). Mung bean nuclease and exonuclease
III were the products of New England BioLabs (Beverly,
Mass.). 5-Fluoroorotic acid was purchased from PCR, Inc.
(Gainesville, Fla.). Isopropyl-p-D-thiogalactoside (IPTG),
5-bromo-4-chloro-3-indolyl-3-D-galactoside (X-Gal), and Se-
quenase DNA sequencing kit were purchased from United
States Biochemical Corp. (Cleveland, Ohio). Deoxynucle-
otides and Miniprep Kit Plus were the products of Pharma-
cia, Inc. (Piscataway, N.J.). Tran35S label was the product
of ICN Radiochemicals (Irvine, Calif.). Multiprime DNA
labeling system, [a-35S]dATP, and [a-32P]dCTP were pur-
chased from Amersham Corp. (Arlington Heights, Ill.).
Nitrocellulose and the Elutrap Electro-Separation Chamber
were the products of Schleicher & Schuell, Inc. (Keene,
N.H.) and were used as instructed by the manufacturer.
Autofluor was purchased from National Diagnostics (Man-
ville, N.J.), Freund complete and incomplete adjuvants were
purchased from GIBCO Laboratories (Grand Island, N.Y.),
and 5(6)-carboxy-2',7'-dichlorofluorescein diacetate (CD
CFDA) was purchased from Molecular Probes, Inc. (Eu-
gene, Ore.). Antiserum against CPY was from Klionsky et
al. (19). All other chemicals were purchased from Sigma
Chemical Co. (St. Louis, Mo.) or other standard sources.
Genetic and DNA manipulations. Standard recombinant
DNA techniques were performed as described previously
(23). Genetic crosses, sporulation of diploids, and dissection
of tetrads were performed according to Sherman et al. (47).
Yeast transformations were done by the lithium acetate
method of Ito et al. (16) in the presence of 10p,g of denatured
salmon sperm carrier DNA.
Chromosomal DNA was isolated and Southern analysis
was performed (23), using DNA fragments containing either
the HIS3 gene or the VPS33 gene as a probe. Northern
(RNA) analysis (23) was carried out by using the 1.1-kilobase
(kb) ClaI-SmaI VPS33 fragment as a probe, and total RNA
was isolated as described by Eakle et al. (9). DNA probes
were labeled by using the Amersham Multiprime DNA
labeling system.
Vectors and plasmid constructions. E. coli plasmids pBlue-
script KS (+) and (-) are described in the Stratagene (La
Jolla, Calif.) catalog. The yeast-integrating vector pPHYI10
(TRPI, selectable marker) and the E. coli-yeast shuttle
vectors pPHYC16 and pPHYC18 (CEN4 ARS1 URA3) will
be described elsewhere (P. Herman, unpublished data). The
E. coli-yeast shuttle vector pSEY18 is a derivative of pSEY8
(11) in which the pUC8 polylinker has been replaced with the
polylinker of pUC18. The HIS3 gene was isolated as a
1.75-kb BamHI fragment from a plasmid kindly provided by
E. Phizicky. The pATH vectors used in the TrpE-Vps33
fusion protein production have been previously described
(6).
The 3.7-kb SalI-XbaI fragment of VPS33 (see Fig. 2B) was
subcloned into the pBluescript KS (+) and (-) vectors to
generate pLB33-211 and pLB33-212, respectively. Plasmid
pLB33-102, used in the integrative mapping experiment, was
constructed by cloning the 5.3-kb SalI-PvuII fragment
shown in Fig. 2B into the SalI-SmaI sites of the yeast-
integrating vector pPHYI10. Construction of pLB33-313,
used in the disruption of VPS33, was achieved by digesting
plasmid pLB33-212 with EcoRI to remove the region shown
in Fig. 2C, gel purifying the resulting linear DNA away from
the two EcoRI fragments, blunting the ends with Klenow
enzyme, and inserting the HIS3 gene as a blunted BamHI
fragment. Recombinant plasmids were selected directly for
the presence of the H1S3 gene in the hisB bacterial strain
JF1754 (25) on M63 minimal medium lacking histidine (28).
In a similar manner, the 2.1-kb HindIII-SmaI fragment
indicated in Fig. 2C was removed and replaced with the
HIS3 gene to generate plasmid pLB33-317. Plasmid pLB33-
221, carrying the VPS33 gene on a multicopy (2 ,um) vector,
was constructed by excising the SalI-XbaI fragment from
pLB33-21 (see below) as a Sall-Sacl fragment (using the
Sacl site in the polylinker) and ligating it to the SalI-Sacl
sites of the 2 p.m vector pSEY18. A truncated form of
VPS33, encoding all but the carboxy-terminal 56 amino acids
(aa) of Vps33p, was constructed by subcloning the 2.7-kb
PstI fragment (Fig. 2C) into the PstI site of pBluescript KS
(-) and then moving this fragment (as a BamHI-SalI frag-
ment) into the corresponding sites in the E. coli-yeast shuttle
vector pPHYC18 to construct pLB33-304. Plasmid pLB33-
162 was constructed by cloning the 3.7-kb SalI-XbaI frag-
ment into the E. coli-yeast shuttle vector pPHYC16.
Cloning and sequence analysis of VPS33. Yeast strain
SEY33-2 was grown in YPD to an optical density at 600 nm
of 0.5 to 1.0 and transformed at room temperature as
described previously (16) with a yeast genomic library
constructed by Rose et al. (41). The library contains inserts
from a partial Sau3A digestion of S. cerevisiae genomic
DNA carried on the E. coli-yeast shuttle vector YCp5O
(CEN4 ARSI URA3). Transformants were selected on SD
lacking uracil at 25°C and replicated to YPD plates, which
were incubated at the restrictive temperature, 37°C. Tem-
perature-resistant transformants were picked, restreaked,
and cured of the plasmid by incubation on 5-fluoroorotic acid
plates (3). Complementing plasmid DNA (pLB33-6) was
isolated and propagated in the bacterial strain MC1061.
Plasmid DNA was transformed into SEY33-2, SEY33-5, and
SEY33-7, and transformants were tested for temperature
sensitivity (growth on YPD at 37°C), osmotic sensitivity
(growth on YPD containing 1.5 M NaCl) (2), vacuolar
protein sorting (40), and vacuole morphology (see below).
The plasmid DNA was also subjected to restriction enzyme
analysis. The restriction fragments shown in Fig. 2B were
isolated from pLB33-6 and subcloned into the appropriate
restriction sites within the polylinker of the E. coli-yeast
shuttle vector pPHYC18 to generate plasmids pLB33-20
through pLB33-24. Plasmid pLB33-21 was digested with Sall
and KpnI, and exonuclease III was used (50) to generate
deletions from the Sall end of the insert. The ends were
blunted by using mung bean nuclease and Klenow enzyme
and religated to generate deletion plasmids pLB33-41 and
pLB33-42. The approximate endpoints of these deletions
were determined by restriction analysis.
Two sets of nested deletion templates for sequencing were
generated by deleting from the Sall end of the insert in
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pLB33-212 and the XbaI end of the insert in pLB33-211,
using exonuclease III (50). Deletions were also generated
from the internal SmaI site in pLB33-211, and additional
templates were constructed by cloning the 0.5-kb EcoRI
fragment, the 1.5-kb ClaI-XbaI fragment, the 0.4-kb PstI-
XbaI fragment, the 2.7-kb PstI fragment, and the 1.4-kb
HindIlI fragment (see Fig. 2C) into pBluescript KS (-).
Single-stranded template DNA was prepared from these
constructs (50) after infection with the helper bacteriophage
VCSM13 (Stratagene), and synthetic primers corresponding
to the T3 or T7 promoter sequence were prepared by DNA
synthesizer. The sequence of both strands of VPS33 was
determined by the dideoxy-chain termination method (46).
DNA sequence and hydropathy analyses (21) were done
by using a program written by K. Eakle (unpublished). A
DNA homology search was performed by using the
TFASTA algorithm, the GENEMBL data bank, and the
University of Wisconsin Genetics Computer Group se-
quence analysis software package. Additional homology
searches using the GenBank, EMBL, NBRF, and SWISS-
PROT protein data bases and the FASTA program (36) were
done on BIONET.
Mapping and rescue of the vps334(Ts) allele. Recombina-
tional rescue analysis was carried out on SEY33-4 carrying
plasmid pLB33-23 or pLB33-24, described above. Additional
plasmids were constructed by cloning the 2.1-kb SmaI-PvuII
fragment, the 2.3-kb SphI-PvuII fragment, and the 0.7-kb
HindIII-SmaI fragment (see Fig. 2B and C) into the appro-
priate restriction sites of pSEY18. In each case, the plasmid
was transformed into SEY33-4 and the frequency of temper-
ature-resistant recombinants was scored.
The vps334(Ts) mutation was rescued by using double-
stranded gap repair (33) as follows. The complete VPS33
gene was subcloned as a 5.3-kb PvuII-SalI fragment into the
E. coli-yeast shuttle vector pPHYC16, and the resulting
plasmid (pLB33-160) was digested with XbaI and SmaI to
generate a gapped linear plasmid. The linear plasmid was gel
purified away from the 0.5-kb SmaI-XbaI fragment. SEY33-
4 was transformed with this plasmid, and Ura+ transfor-
mants were scored for temperature sensitivity. Plasmid
DNA (designated pLB33-161) carrying the rescued vps33-
4(Ts) allele was purified. The Smal-XbaI fragment carrying
the mutation was isolated and subcloned into pBluescript KS
(-). Double-stranded DNA was isolated by using the Phar-
macia Miniprep Kit Plus and sequenced. The VPS33 gene
carrying the vps334(Ts) mutation was excised from pLB33-
161 as a SailI-Sacl fragment (using the SacI site in the
polylinker) and cloned into the 2 ,um vector pSEY18 to
generate pLB33-271.
Antibody production. trpE-VPS33 gene fusions were con-
structed by using the two fragments of the VPS33 gene
depicted in Fig. 2C. The 0.7-kb HindIII-SmaI fragment was
isolated from pLB33-21, blunted by using Klenow enzyme,
and ligated to the blunted SalI site of the pATH3 vector to
generate an in-frame fusion encoding aa 379 to 608 of
Vps33p. The 0.5-kb EcoRI fragment was isolated, blunted as
described above, and ligated into the SmaI site of the
pATH2 vector to generate an in-frame fusion encoding aa
140 to 303 of Vps33p. Individual transformants were puri-
fied, and the presence and orientation of the VPS33 se-
quence was confirmed by restriction analysis. Bacterial
strains carrying candidate fusion constructs were assayed
for the production of fusion protein (48). Whole-cell lysates
and insoluble fractions were prepared basically as described
by Kleid et al. (18) (except that 2% Triton X-100 was used
rather than 0.2% Nonidet P-40) and subjected to sodium
dodecyl sulfate-9% polyacrylamide gel electrophoresis (22).
Inducible fusion proteins of the expected molecular sizes (62
and 55 kDa) were the predominant bands visualized in the
insoluble fractions upon Coomassie staining. The bands
containing the fusion proteins were excised from Coomassie-
stained preparative gels and electroluted from the gel slices
by using a Schleicher & Schuell Electro-Separation Cham-
ber. Approximately 175 ,ug of each purified fusion protein,
emulsified with Freund complete adjuvant, was injected
intramuscularly and subcutaneously into a young male New
Zealand White rabbit. After 4 weeks, the rabbit was boosted
with 25 ,ug of each fusion protein in an emulsion with Freund
incomplete adjuvant. Antisera were screened by immuno-
precipitation. A titration curve was generated for these
antisera to determine the amount needed for a quantitative
recovery of overproduced levels of Vps33p.
Immunoprecipitation. Cells were grown in SD medium (47)
supplemented with the appropriate amino acids. Whole cells
(1.5 U at an optical density at 600 nm of 1.0) were collected
by centrifugation. The cells were resuspended in 0.5 ml of
the same medium, and 125 ,uCi of Tran35S label was added.
The cells were labeled for 20 min with shaking at the
appropriate temperature. A 30-min chase was initiated by
the addition of methionine to a final concentration of 4 mM.
The chase was terminated, and cells were lysed and sub-
jected to a single round of immunoprecipitation, using anti-
serum specific for Vps33p or CPY as described previously
(9, 19).
Cell fractionation. Cells were grown in SD medium (47) as
described above. Six units of cells at an optical density at 600
nm of 1.0 were harvested by centrifugation and sphero-
plasted in the same medium as described previously (40).
Spheroplasts were labeled and chased as described above.
All subsequent manipulations were performed at 4°C. La-
beled spheroplasts were pelleted at 1,200 x g for 2 min. The
spheroplasts were suspended in 1 ml of lysis buffer (50 mM
Tris chloride [pH 7.5], 1 mM EDTA, 5 mM MgCl2, 1 mM
phenylmethylsulfonyl fluoride, 1 ,uM leupeptin, 1 mM so-
dium azide, 0.125 mg of a2-macroglobulin per ml) with
various concentrations of KCI as indicated and vortexed for
30 s. In some experiments, the lysis buffer also contained 0.3
M mannitol or 0.8 M sorbitol for partial osmotic support (29,
45). Unlysed spheroplasts were removed by centrifugation at
500 x g for 2 min and subjected to a second round of lysis.
Unlysed spheroplasts were removed as before, and the
lysates were pooled and immediately centrifuged at 100,000
x g for 90 min. The pellet was rinsed gently with 1 ml of lysis
buffer and suspended in 1 ml of0.5% sodium dodecyl sulfate.
Supernatant and pellet fractions were precipitated with
trichloroacetic acid (5% final concentration) and immunopre-
cipitated.
Fluorescent labeling of cells and microscopy. Cells were
grown in YPD, labeled with CDCFDA or fluorescein isothio-
cyanate (FITC), and observed as described previously (2,
37, 38).
GenBank accession number. The GenBank accession num-
ber for the sequence reported in this paper is M34638.
RESULTS
Cloning and genetic analysis of the VPS33 gene. The VPS33
gene was cloned by complementation of the vps33-2(Ts)
mutation (in the Ura3- strain SEY33-2) with a yeast genomic
library carried on the single-copy vector YCp5O (41). Among
11,000 Ura+ transformants, 7 were temperature resistant.
Upon curing of these transformants of the plasmid, five
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FIG. 1. Complementation of vps33-2(Ts) by the cloned VPS33
gene. The parental strain SEY6210, the SEY33-2 mutant strain
without and with the complementing plasmid pLB33-21, and the
isogenic vps33 null mutant LBY317 were streaked on YPD solid
media and incubated at 25 or 37°C, as indicated.
A: Xb Xh S C C Xh Sm Xb
remained temperature resistant, indicating that the temper-
ature resistance was not dependent on the presence of the
plasmid. The remaining two transformants were temperature
sensitive when cured, suggesting that the temperature-resis-
tant phenotype was indeed conferred by the plasmid. Re-
striction analysis of the purified plasmid from these two
transformants revealed that the two complementing plas-
mids contained identical inserts. Retransformation of
SEY33-2 and two other vps33 strains demonstrated that this
plasmid, designated pLB33-6, complemented all of the phe-
notypes associated with the vps33 mutations, including
temperature sensitivity (Fig. 1), mislocalization of vacuolar
proteins (see Fig. 5), osmotic sensitivity, and the defect in
vacuole biogenesis (data not shown).
A restriction map of the 12-kb insert in pLB33-6 is shown
in Fig. 2A. Subcloning and complementation analysis (Fig.
2B) indicated that the complementing activity resided on a
3.7-kb SalI-XbaI fragment. Removal of as much as 1,000
base pairs (bp) from the Sall end, using exonuclease III, did
not destroy the ability to complement.
To confirm that this complementing ability was not due to
suppression by another gene, we carried out integrative
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I
N
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B: I
S P PC H R CRRH XhSpSmP
. .
\P 33
-I pLB33-20
pLB33-21
pLB33-22
pLB33-23
pLB33-24
pLB33-41
pLB33-42
Xb
Xb
Xb
Open Reading Frame
pLB33-313 (A33)
pLB33-317 (A33)
Fragnents Used in
MM&&QQ Antibody Production
FIG. 2. (A) Restriction map of the entire 12-kb VPS33 complementing clone. Restriction site abbreviations: B, BamHI; C, ClaI; Pv, PvuIl;
S, SaII; Sa, Sacl; Sm, SmaI; Xb, XbaI; Xh, XhoI. (B) Complementation analysis of the VPS33 subclones. Restriction fragments were cloned
into pPHYC18 (CEN4 ARSI URA3) to generate pLB33-20, pLB33-21, pLB33-22, pLB33-23, and pLB33-24. Plasmids pLB33-41 and
pLB33-42 were the result of exonuclease III deletions from the Sall end of the complementing fragment in pLB33-21 to yield the endpoints
shown. The plasmids were transformed into SEY33-7, and Ura+ transformants were tested for growth at 37°C. Vacuole morphology, as
assessed by staining with CDCFDA (see Materials and Methods), was also scored. Symbols: +, the transformants were temperature resistant
and exhibited class A (wt) vacuole morphology; -, the transformants had a temperature-sensitive class C phenotype. (C) Fragments used for
antibody production and gene disruption. The position of the ORF as determined by sequencing is shown. Plasmids pLB33-313 and
pLB33-317, in which the HIS3 gene replaced the indicated portions of VPS33, were used to generate vps33 null mutants as described in the
text. , Fragments used to generate in-frame trpE-VPS33 gene fusions. The encoded hybrid proteins were used in antibody production as
described in Materials and Methods. Additional restriction site abbreviations: H, Hindlll; P, PstI; R, EcoRI; Sp, SphI.
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mapping studies with the clone. The complementing 5.3-kb
SaIl-PvuII fragment (Fig. 2B) was cloned into the integrating
vector pPHYI10, which carries the selectable marker TRPJ.
The resulting plasmid was linearized at the internal XhoI site
to facilitate homologous recombination (32) and was trans-
formed into a Trpl- strain harboring the vps33-7(Ts) muta-
tion. Trp+ temperature-resistant transformants were crossed
to the Trpl- VPS+ parental strain SEY6210. Tetrad analysis
of the sporulated diploids showed the expected 2:2 Trp+:
Trp- segregation pattern; all four spores in each of the 12
asci analyzed were temperature resistant and exhibited wt
vacuolar morphology. Further analysis of 190 random spores
also failed to uncover any temperature-sensitive segregants,
whereas the Trp+:Trp- phenotype segregated 97:93. These
observations demonstrated that the complementing clone is
tightly linked to the vps33 mutant locus.
The complementing SalI-XbaI fragment was also cloned
into the 2 ,um (multicopy) vector pSEY18 to generate the
plasmid pLB33-221. Yeast transformants harboring this plas-
mid overproduced the VPS33 gene product -20-fold (see
below). Transformation of SEY33-7 or wt strains with
pLB33-221 resulted in a Vps+ phenotype, indicating that
severalfold overproduction of the VPS33 gene product is not
detrimental to otherwise wt cells. We also transformed
pLB33-221 into a representative allele of each of the other
three class C complementation groups, vpsll, -16, and -18.
In no case did the plasmid suppress any of the defects
associated with these mutations; thus, overproduction of
Vps33p appears unable to rescue any of these phenotypically
similar mutants.
VPS33 sequence analysis. The nucleotide sequence of
VPS33 was determined by sequencing a series of nested
exonuclease 111-generated deletion templates by the dideox-
ynucleotide-chain termination method (46). The DNA se-
quence (Fig. 3) contains a single long open reading frame
(ORF) of 2,073 bp, with the potential to encode a protein of
691 aa. Examination of the 5' noncoding sequences revealed
a possible transcription initiation sequence, TATATTAA
(31), at position -157 relative to the putative translational
initiation codon. A consensus sequence for transcription
termination, TAG....TAGT ....TTTT (31) (underlined in Fig.
3), is found 147 bp downstream of the ORF stop codon TAA.
Northern analysis was performed, using an internal fragment
of VPS33 as a probe to identify the VPS33 transcript.
Consistent with the ORF size predicted from the DNA
sequence, a single RNA species of 2.2 kb was detected (data
not shown).
The sequence of the predicted VPS33 gene product was
subjected to hydropathy analysis according to the model of
Kyte and Doolittle (21). The predicted Vps33 polypeptide is
hydrophilic (26% charged amino acids), with no apparent
hydrophobic domains that could span a membrane or func-
tion as a signal sequence (data not shown). A search for
sequence homology using the GENEMBL data bank and the
TFASTA algorithm (36) revealed that the 3' end of the
VPS33 gene (nucleotides 2307 to 2695) is identical to the
sequence upstream of the yeast COX8 gene, which encodes
the cytochrome c oxidase subunit VIII. Furthermore, the
published sequence of the COX8 gene contains a short ORF
5' of the COX8 coding region which corresponds to the last
55 codons of the VPS33 ORF (35). From these results, we
conclude that the VPS33 gene lies next to the COX8 gene in
the yeast genome. Sequence analysis also revealed an ORF
5' of the VPS33 gene. An interesting sequence similarity was
noted between this ORF and three other proteins: the
mammalian N-ethylmaleimide-sensitive factor (56), its yeast
homolog Secl8p (9), and a protein of unknown function,
porcine valosin-containing protein (20). The significance of
this sequence similarity is not known; however, gene disrup-
tion of the ORF 5' of VPS33 appears to result in lethality
(L. M. Banta, K. A. Eakle, and S. D. Emr, unpublished
observations).
Further homology searches using the GenBank, EMBL,
NBRF, and SWISS-PROT protein data bases uncovered no
additional significant sequence similarities (36). However, a
manual search of the predicted amino acid sequence re-
vealed two regions of sequence similarity with a number of
known and predicted ATP-binding proteins. These two areas
of similarity are conserved in a diverse assortment of
ATPases and ATP-binding proteins, including the E. coli
ATPase a and i subunits, myosin, and phosphofructokinase
(Fig. 4), and a consensus sequence has been determined (53).
The two domains are often separated by 60 to 100 aa, and
some proteins (e.g., myosin and phosphofructokinase) con-
tain only one of the two regions. In Vps33p, the two regions
are located at residues 480 to 498 and 661 to 679 (Fig. 3).
Disruption of VPS33. Disruption of the VPS33 locus was
accomplished by using the one-step gene disruption tech-
nique (44) with two different constructions. In the first, the
700-bp EcoRI fragment shown in Fig. 2C was replaced with
the HIS3 gene. This disrupted VPS33 construction was
digested with Sall and XbaI and used to transform the
parental his3-A200 diploid SEY6210/SEY6211. Two different
resulting His' transformants were subjected to tetrad anal-
ysis. In each of the 10 asci examined, all spores were viable
but a segregation pattern of 2 temperature-sensitive His+:2
temperature-resistant His- spores was observed. Micro-
scopic examination of the temperature-sensitive segregants
streaked on YPD revealed that the cells doubled at most two
times at 37°C. A second construction replaced the entire
2.1-kb HindIII-SmaI fragment (indicated in Fig. 2C) with the
HIS3 gene. This construction deleted all but the carboxy-
terminal 250 bp of the putative VPS33 ORF. Transformation
of the haploid strain SEY6210 with the linear SalI-XbaI
fragment carrying this construction yielded temperature-
sensitive His+ transformants. The temperature-sensitive
phenotype of one such transformant, LBY317, is shown in
Fig. 1. In liquid media, this strain doubles 1.5 times at 37°C
and exhibits a terminal arrest phenotype in which, after 24 h
at 37°C, approximately 50% of the cells contain a medium or
large bud and an additional 20% contain two or more buds.
Southern analysis of the chromosomal DNA from these
disrupted strains confirmed the removal of the VPS33 se-
quences and the integration of the HIS3 gene at the VPS33
locus as expected (data not shown). From these results, we
conclude that VPS33 is not essential at low temperatures but
is required for growth at 37°C.
As expected, disruption of the VPS33 gene also led to the
other phenotypic defects associated with the original mutant
alleles. Strains harboring a disrupted VPS33 gene exhibited
extreme defects in vacuole morphology and in vacuole
protein localization and processing at the permissive temper-
ature (Fig. 5). The vps33 null mutant strain LBY317 was
radioactively labeled at 25°C for 20 min and chased for 30
min before immunoprecipitation with antiserum specific for
the vacuolar protease CPY. CPY was present almost exclu-
sively in the precursor form in these cells (Fig. 5, lane 2),
whereas in wt cells labeled under identical conditions, 100%
of the CPY was present in the mature vacuolar form (lane 1).
Previous characterization of vps33 mutants has demon-
strated that most (>70%) of the precursor CPY is secreted
from the cell (40). The Vps- defect exhibited by the null
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1 GTCAAGAAOC 000CTTOOC GCCATAAT0G AAGATTTAGA TGT =MAA GTOOAATTAC GTCATTTTGA GMA0ACTTTT AAAOGAATTG CTAGGO0OAT 100
101 TACTCCAGAA ATGCTCTCTT ATTATGAAGR GTTTGCTCTA AGAAGCOTT CATCTTCGTA AOCTTOTTCA TAGTCALATTC TTTTCCTTTG TGTGCTCAAT 200
201 AATAGTAGALT AGAMATTATA CTCAACTOM GTCATTTTGT ATAATATATT__MTCACTTCA CACGAACATA CATAAATAAA ATATCATAAA OOTTAGCAAA 300
301 TTOGGACTAG TTATATGTTA ATTAGTTAAA AGOATAGAAAA TTCOAGAAAG G&AGAAAAAG CTGATATTGC CCALTCTCCAA CTTTATCAAA TCATTTCACG 400
401 ATO AALT AGA TTT TOG AAT ACT MAG AAA TTT TCAL TTA ACA AAT GCC OALT GGA CTA TGT OCT ACC TTA AAT GALG ATA TOT CAA AAT OILT GAA 490
1 Hot kAn Ar; Ph. Trp Asn Thr Lys Lys Ph. Ser Lou Thr Asn Ala Asp Gis' Lou Cys Ala Thr Lou Asn Giu Ile Sor Gin Asn Asp Glu 30
491 OTT CTT GTO OTT CMA CCA AGT GTA TTO CCA GTA CTC AAT AGT TTG CTA ACT TTC CAA OAT TTG ACT CAA TCA ACT CCT GTA AGO AAA ATT 580
31 Val Lou Val Val Gln Pro Sor Val Lou Pro Val Lou Asn Sor Lou Lou Thr Ph. Gln Asp Lou Thr Gin Sor Thr Pro Vai Arg Lys Ile 60
581 ACG TTA CTC OAT OAT CAG CTA AGT GAC OAT_TTA CCG AGT 0CC TTA GGC AGC GTT CCG CM& ATG OAT CTT ATT TTT CTT ATT OAT GTIC AGA 670
61 Thr Lou Lou Asp Asp Gin LAu Sor Asp Asp Lou Pro Sor Ala Lou Gly' Sor Val Pro Gin Not Asp Lou Ile Ph. Lou Ile Asp Val Ar; 90
671 ACA TOT CTC COA CTC CCT CCA CMA CTG CTT OAT OCT OCT CAkA AAG CAC AAT TTA TCA TCT TTG CAT ATA ATA TAC TOT CGOA TOO AAA CCG 760
91 Thr Sor Lou Ar; Lou Pro Pro Gin Lou Lou Asp Mla Ala Gin Lys His Msn Lou Sor Sor Lou His Ile Ilie Tyr Cys Ar; Trp Lys Pro 120
761 CT TTO CAA AAT ACT TTG GAO OAT ACA GAO CMA TOG CMA AMG OAT GOT TTC OAT TTG MAT TOA AMA AMA ACA CAT TTC CCT AAC GTO ATT 850
121 or Pho Gin Msn Thr Lou Glu Asp Thr Glu Gin Trp Gin Lys Asp Gly Ph. Asp Lou Asn Sor Is's Is's Thr His Ph. Pro Msn Vai Ile 150
851 MA TOT CAG TTA MAG GAG CTA TOG MAC GMR TAT ACC CTT TAC CCT TOO OAT CTOC TTG CCC TTC CCA CAG ATT OAT GMA MAT OTT CTA TTO 940
151 iu Sor Gin Lou Lys Glu Lou Sor Msn Giu Tyr Thr Lou Tyr Pro Tsp Asp Lou Lou Pro Ph. Pro Gin Ile Asp Glu Asn Val Lou Lou 180
941 ACT CAT TCC CTT TAT AAC ATO GM MAT GTA MAC ATG TAT TAT CCC AAC TTA CGT TOT TTG CAG AOT GCC ACA GAG TOA ATA CTO OTT OAT 1030
181 Thr Ris Sor Lou Tyr Asn Hot Glu Msn Val Msn Hot Tyr Tyr Pro Msn Lou Ar; Sor Lou Gin Sor Ala Thr Glu Sor Ilo Lou Vai Asp 210
1031 OAT ATO GTO MRT TOO TTO CAG AOC TTO ATT TTT GMA ACT MAT AOT ATO ATA ACA MRT OTT GTG TCG ATA GOT MAT CTG TOT AAG AGA TOT 1120
2i1 Asp Host Val Msn Sor Lou Gin Sor Lou Ile Ph. Giu Thr Msn Sor Ile Ilo Thz Msn Vai Val Sor Ilo Gis' Mn Lou Sor Ls's Ar; Cs's 240
1121 AOC CAT CTT TTG MAG AMA CGA ATO OAT GAO CAT CMA ACA GOGOAMT OAT TTA TTO ATC AAG GOT ACG CTT TAT GOT GMA COA ACC AAC TOT 1210
241 Sor His Lou Lou Ls's Lys Ar; Ilo Asp Glu His Gin Thr Glu Asn Asp Lou Ph. Ilo Lys Gly Thr Lou Tyr Gly Glu Ar; Thr Asn Cs's 270
1211 OGG CTA GMA ATO GAC TTO ATT ATO TTG GMA AGO MAT ACC OAT CCT ATA ACG CCA TTG TTO ACA CMA CTT ACG TAT OCA GGA ATA CTA OAT 1300
271 Gly Lou Glu Hot Asp Lou Ilo Ilie Lou Glu Ar; Msn Thr Asp Pro Ilo Thr Pro Lou Lou Thr Gin Lou Thr Tyr Mla Gis' Ilo Lou Asp 300
1301 OAT CTA TAT GMA TTC MAT TOT GOC ATA MAG ATA MAG GAG AMA GAC ATO MAC TTO MAT TAT MAG GMA OAT AMA ATA TOG MAT OAT TTG MAA 1390
301 Asp Lou Tyr Glu Pho Asn Sor Gis' Ilo Ls's Ilo Lys Glu Lys Asp Hot Msn Pho Msn Tyr Lys Giu Asp Ls's Ilo Tsp Asn Asp Lou Ls's 330
1391 TTT TTA MAT TTT 000 TCG ATT GOG CCG CAG TTA MAT AMA TTG GCA MAG GMA CTA CMA ACG CMA TAT OAT ACA AGO CAT AMA GCC GAG AGC 1480
331 Ph. Lou Asn Ph. Gly Sor Ile Gis' Pro Gin Lou Msn Lys Lou Ala Lys Glu Lou Gin Thr Gin Tyr Asp Thr Ar; His Lys kla Giu Sor 360
1481 GTA CAT GMA ATO AMA GM TTC OTT OAT TCC TTA GOT TOT TTG CMA CMA AGG CMA OCT TTT TTG AMA MT CAC ACA ACC TTA TOA TCC GAC 1570
361 Vai His Glu hIle Lys Glu Ph. Vai Asp Sor Lou Gly Sor Lou Gin Gin Ar; Gin Mla Pho Lou Lys Msn His Thr Thr Lou Sor Sor Asp 390
1571 OTT TTO AMA GTO OTA GAG ACT GMA GAG TAC OGG TOT TTO MAT AMA ATO TTA GAG TTA GAG CTG GMA ATT TTG ATGO GA MAT ACA CTT MAT 1660
391 Val Lou Lys Val Val Glu Thr Glu Glu Ts'r Gly Sor Ph. Msn Lys hIse Lou Glu Losu Giu Lou Giu Ile Lou Host Gis' Asn Thr Lou Msn 420
1661 MAC GAC ATT GMA OAT ATT ATA CTO GAG TTO CAG TAC CAG TAC GAG OTT OAT CMA MG AAG ATT CTO AGA TTA ATO TOT TTA TTG TCT CTT 1750
421 Asn Asp Ilo Giu Asp Ilo Ilo Lou Giu Lou Gin Ts'r Gin Ts'r Glu Val Asp Gin Lys Lys Ise Lou Ar; Lou hI.e Cs's Lou Lou Sor Lou 450
1751 TOT MRA MAT TOA CTT COA GMA AAG OAT TAT GMk TAT CTA AGA ACC TTT ATG ATO OAC TCT TOG GOC ATT GMA MAA TOC TTT CMA CTT GMA 1840
451 Cs's Lys Asn Sor Lou Ar; Glu Lys Asp Tyr Glu Ts'r Lou Ar; Thr Ph. Nost hIse Asp Ser Tsp Gly Ile Glu Is's Cs's Ph. Gin Lou rGiu` 480
1841 TCA TTO GCT GAO rTA OGA TTT TTO ACT AGC MAA ACG GGA MAA ACT OAT TTG CAT ATT ACA ACA AOT AAG TOA ACA AGA TTA CAG AMA GMA 1930
481 Sor LouAla Gu LouGs'Peh Tr Sers'ys TrGly'Lys'ThrAspLou-Hislle Thr Thr SorLys'sSr ThrAkr;Lou GlnLys' Giu 510
1931 TAC COT TAT ATT TOA CMA TOG TTO MAT ACA OTA CCC ATA GMA GAC GAG CAT OCT GCC OAT MAA ATO AC AAMT GAG MAC OAT GAkC TTO TOG 2020
511 Ts'r Ar; Tyr hIse Sor Gin Tsp Ph. Msn Thr Vai Pro Ilo Glu Asp Glu His Ala Ala Asp Is's Iie Thr Msn Glu Msn Asp Asp Ph. Sor 540
2021 GM 0CC ACT TTT OCT TAC AGT GOT OTA GTO CCC TTG ACA ATO AGA CTG OTT CAG ATG TTA TAT OAT AGO TOT ATO TTG TTO CAT MAT TAT 2110
541 Glu Mla Thr Pho Mla Tyr Mer Gis' Vai Val Pro Lou Thr lHot Ar; Lou Vai Gin lHot Lou Ts'r Asp Ar; Mer hI.e Lou Ph. His Asn Ts'r 570
2111 TCC TOG CAG CAG CCT TTT ATA CTO TOA AGA GMA CCT AGA OTT TCT CMA ACG GAG OAT TTA ATT GMA CAG TTA TAT GGA GAC TOA CAT 00G 2200
571 Ser Mer Gin Gin Pro Ph. hI.e Lou Mer Ar; Glu Pro Ar; Val Sor Gin Thr Glu Asp Lou Ilo Glu Gin Lou Ts'r Gis' Asp Mer His Mla 600
2201 ATOC GMi GAG AGT ATA TGG OTC CCG GGA ACC ATT ACA MAA MAG ATO MAT OCA AGC ATC AAG AGC MAT MAT AGA COO TOC ATA GAC OGG TOT 2290
601 Ilo Glu Giu Mer Ile Tsp Val Pro Gis' Thr Ile Thr Is's Is's Ile Msn Mla Mr Ile Is's Mr Asn Msn Ar; Ar; Mer hI.e Asp Gis' Mrx 630
2291 MAT 000 ACA TTT CAT OCT OCA GAG OAT ATT GCA CTC GTA GTA TTO CTO GGA GOT OTA ACA ATG GOT GMA ATA OCT ATA ATO AAG CAT TTO 2380
631 Asn Gis' Thr Ph. His Ala Mla Glu Asp hIle Mla Lou Val Val Ph. Lou Gis' Gis' Vai Thr list Gis' Glu Ile Mla Ile Not Is's His Losu 660
2381 CMA MAA ATA CTA GOT MAA MAA GOT ATO MAT MAA AGG TTT ATO ATO ATCO0CC OAT GGC TTO ATO MAT GOC ACA AGO ATO ATO MAC TOT ATA 2470
661 [Gin Is's Ii. Lou Gis' Is's Is's Gis' hIse An Is's Ar; Ph. hI.e hI.e hIle Ala Asp Gis' Lou Ilo Asn Gis' Thr Ar; hI.e Net Msn Sor hIle 690
2471 TOT TMA TTATTATATO ATAGATTTOT TMATTTTTTG TATATGCAMA TOTOCTTTTT TTOACCAMAC GG;TTTGCACC MATOATACGA GAGAAOTOTT 2566
691 Sor END 691
2567 CGGTOTTTAC OGOAAOACTA GOGOACTMAG MAMAATTOML MTMAGGCT GACAGCAOTA__AMACCATTG TOCTGGCTTA__GTGATTTATA AGMATOOTTA 2666
2667 ATTAOTTTTG TATCCTTTM TTTCTAGA 2695
FIG. 3. Sequence of VPS33. The nucleotide sequence and the deduced amino acid sequence of the ORF are shown. The putative
transcription initiation and termination sequences are underlined. The regions which share sequence similarity with ATP-binding proteins are
boxed. The T marked with an asterisk is replaced with a C in vps33-4(Ts).
mutant was completely complemented when the wt VPS33 the expected molecular weights were overproduced upon
gene was present on a single-copy vector (lane 3). induction. Both overexpressed proteins were isolated and
Identification of Vps33p. To identify Vps33p, we overpro- injected into a single rabbit as described in Materials and
duced the VPS33 gene product as two different TrpE-Vps33 Methods. The resulting antisera were used in immunopre-
hybrid proteins in E. coli and raised antisera against the cipitation experiments to detect Vps33p. The antibodies
fusion proteins. Two coding fragments of the VPS33 gene, recognized a single major species of the predicted molecular
from HindIII-Smal and from EcoRI-EcoRI, were cloned into weight, -75,000, in radioactively labeled wild-type cells
the appropriate pATH vectors (6) to generate in-frame (Fig. 6, lane 1). This protein was -20-fold more abundant
fusions to the trpE gene of E. coli. These fragments (Fig. 2C) when the VPS33 gene was present on a multicopy plasmid
encode 230l -An 16KAa repetiel,f V 3p.When, ths flane, 2) and% wasc nodtecteda in% thea vps33Z nuill muitant (lane
constructions were expressed in E. coli, hybrid proteins of 5) or by the preimmune serum (lane 6). Pulse-chase analysis
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Domain A:
Vps33p
SeclBp
RecAp
ATPase a
ATPase 0
Myosin
DnaBp
Rad3p
Adenyl . Kinr.
Endip
Domain B:
Consensus:
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(557-573):
( 59-76 ):
(163-179):
(144-160):
(172-188):
(222-240):
( 37-52 ):
( 8-25 ):
(130-145):
Consensus:
Vps33p (661-679):
Secl8p (574-591):
ATPase a (266-283):
ATPase I (228-245):
Adenyl.Kin. (103-120):
PFK ( 86-103):
Endlp (147-165):
E
V
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Q
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N
S
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FIG. 4. Comparison of the predicted Vps33p sequence with known and predicted ATP-binding proteins. The deduced amino acid sequence
of Vps33p shares similarity with the proteins listed through the two domains shown. Residues that are highly conserved at a given position
are shown in boldface and boxed. and a consensus sequence is indicated above each domain. The significance of the starred lysine in domain
A is discussed in the text. In domain B, asterisks denote hydrophobic residues; this region is followed by an aspartic acid in one of the next
three positions in each of the proteins listed (53). The sequences shown are taken from Walker et al. (53) (E. coli ATPase a and 3 subunits,
adenylate kinase [Adenyl. Kin.], rabbit myosin, phosphofructokinase [PFK], and RecAp), Naumovski and Friedberg (30) (DnaBp and
Rad3p), or Dulic and Riezman (8) (Endlp). By analogy to the N-ethylmaleimide-sensitive factor of mammalian cells, with which it is
functionally equivalent (56), the yeast Secl8p (9) is also predicted to bind ATP.
suggests that the turnover rate for Vps33p is relatively slow;
after a 30- or 90-min chase, there was no significant differ-
ence in the amount of the protein produced from a multicopy
plasmid. Comparison with CPY indicates that the VPS33
gene product is present at very low levels in wt yeast cells.
By densitometric quantitation, we estimate that the produc-
tion of Vps33p from the multicopy plasmid is comparable to
the level of expression of CPY from the chromosomal locus
(0.05 to 0.1% of the total cell protein). Cells were also
labeled in the presence of tunicamycin, an inhibitor of
N-linked glycosylation (10). The size of Vps33p was unaf-
fected by the drug (Fig. 6, lanes 3 and 4), indicating that none
of the seven potential sites for N-linked carbohydrate addi-
tion (24) (Asn-X-SerlThr) is utilized.
The subcellular localization of Vps33p was examined by
cellular fractionation and immunoprecipitation studies.
Wild-type cells carrying VPS33 on a multicopy plasmid were
converted to spheroplasts, radioactively labeled, and osmot-
ically lysed under a variety of conditions before being
subjected to centrifugation at 100,000 x g for 90 min. These
centrifugation conditions were sufficient to pellet >95% of
the vacuolar membrane protein alkaline phosphatase,
whereas the cytosolic marker enzyme glyceraldehyde 3-
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FIG. 5. Processing ofCPY in a vps33 null mutant in the presence
and absence of the cloned VPS33 gene. Whole cells were labeled
with Tran35S label for 20 min at 25°C, chased for 30 min by the
addition of 4 mM methionine, and subjected to immunoprecipitation
with CPY-specific antisera. The migration positions of precursor
(proCPY) and mature (mCPY) forms are indicated. The isogenic
strains used were as follows: lane 1, VPS' (SEY6210); lane 2, vps33
null mutant (LBY317); and lane 3, vps33 null mutant carrying the
cloned VPS33 gene on a single-copy plasmid [LBY317(pLB33-162)].
FIG. 6. Identification of the VPS33 gene product. Spheroplasts
(A) or whole cells (B) were labeled and chased as described in the
legend to Fig. 5. Strains used were parental strain SEY6210 (lane 1),
SEY6210 carrying VPS33 on the multicopy plasmid pLB33-221
(lanes 2, 3, 4, and 6), or the vps33 null mutant LBY317 (lane 5).
Tunicamycin was added to a 20-tLg/ml final concentration as indi-
cated 15 min before the addition of the radioactive label. Immuno-
precipitations were performed by using the preimmune (lane 6) or
Vps33p immune (lanes 1 to 5) sera. The migration positions for
molecular size standards are indicated in kilodaltons (kd). In panel
A, the exposure time for lane 1 was twice as long as for lane 2.
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FIG. 7. Subcellular fractionation of Vps33p. Strain SEY6210
carrying VPS33 on the multicopy plasmid pLB33-221 was enzymat-
ically converted to spheroplasts. Spheroplasts were labeled at 30°C
for 20 min and chased for 30 min by the addition of 4 mM
methionine. Labeled spheroplasts were pelleted and osmotically
lysed as described in Materials and Methods in lysis buffer contain-
ing the indicated concentration of KCI. Two representative condi-
tions are shown; other concentrations of KCI (100 mM, 250 mM, and
1 M) gave identical results. Unlysed cells were removed by centrif-
ugation at 500 x g, and the resulting lysate was centrifuged at
100,000 x g for 90 min at 4°C. The supernatant (S) and pellet (P)
fractions were processed as described in Materials and Methods and
immunoprecipitated with antiserum to Vps33p.
phosphate dehydrogenase was found exclusively in the
supernatant fraction (data not shown). The results of two
representative experiments are shown in Fig. 7. Vps33p was
found primarily in the supernatant fraction; this solubility
was not affected by varying the salt concentration of the lysis
buffer from 0 to 1 M KCI or by varying the pH of the lysis
buffer (7.5 to 6.5 or 8.0) (44) (data not shown). These results
suggest that the VPS33 gene product resides in the cyto-
plasm and is not tightly associated with any membrane
fraction. Vps33p expressed from the chromosomal VPS33
locus, although considerably more difficult to detect, also
behaved as a soluble cytosolic protein in cell fractionation
studies (data not shown). These observations do not, how-
ever, exclude the possibility that Vps33p associates weakly
or transiently with some subcellular membrane or complex.
By immunofluorescence studies, we have detected a weak
background fluorescence that may be due to cytoplasmic
staining (data not shown).
vps33 mutant strain SEY33-4 exhibits a bud vacuole defect.
Wild-type vacuoles can be visualized in live cells by using
various dyes, including CDCFDA (38) and FITC (37), that
accumulate in this organelle. As previously mentioned, most
of the class C vps mutants exhibit extreme defects in vacuole
morphology in that they contain no compartments that
resemble wt vacuoles. Instead, they accumulate many small
vesicles and other membranous structures (2). When these
class C vps mutants are stained with CDCFDA or FITC,
only small speckles of fluorescence are detected. Two vps33
mutant strains, SEY33-4 and SEY33-5, however, do not
exhibit these gross abnormalities in their vacuole morphol-
ogies. Instead, they contain vacuoles that stain like those in
wt cells. Unlike the other, more extreme vps33 mutants,
these strains also are not sensitive to osmotic stress. Fur-
thermore, SEY33-4 and SEY33-5 are only moderately defec-
tive in vacuole protein localization, missorting -40% of the
soluble vacuolar protease CPY. One of these strains, how-
ever, is temperature sensitive for growth. This strain,
SEY33-4, was found to contain morphologically wt vacu-
oles, as visualized by using either CDCFDA or FITC, in
both the mother cell and the bud at 25C, the permissive
temperature (Fig. 8A and B). However, when the strain was
shifted to the nonpermissive temperature (37°C) for 2 h,
budding cells were observed in which the bud did not appear
to have any stain (Fig. 8C and D). Incubation for longer
times at 37°C resulted in fewer buds with detectable vacuole
staining (Fig. 8E to J). By 6 h after the shift to 37°C, only a
small fraction of the buds had vacuole fluorescence, and
some unbudded cells exhibited a typical class C phenotype
in that little or no vacuole fluorescence was visible (Fig. 8J).
The wt parental strain SEY6210 is shown for comparison in
Fig. 8K and L. Under identical staining conditions, bud
vacuole fluorescence was clearly visible in these cells at 25°C
(Fig. 8K) or after 6 h at 37°C (Fig. 8L). The extent of the bud
vacuole staining defect in SEY33-4 was quantitated (Fig. 8).
When SEY33-4 was grown at 25°C, 80% of the buds exam-
ined contained vacuole fluorescence. After 6 h at 37°C, only
14% of the buds exhibited vacuole staining. The vacuole
protein processing phenotype of SEY33-4 was also exacer-
bated by exposure to 37°C. After 6 h at 37°C, -70% of the
CPY accumulated in the precursor form, as compared with
40% at 25°C (Fig. 9B; compare lanes 2 and 6). The temper-
ature-sensitive mutation and the bud vacuole defect in
SEY33-4 are genetically linked to the vacuole protein proc-
essing defect (2, 40), and each of the defects is completely
complemented by the cloned VPS33 gene.
The vps334(Ts) mutation results in a Leu-646 -* Pro
change. The temperature-sensitive mutation in SEY33-4 was
mapped by using a strategy of recombinational rescue.
Initially, SEY33-4 was transformed with the noncomple-
menting plasmid pLB33-23 or pLB33-24 (Fig. 2B); transfor-
mants streaked on YPD plates were incubated at 37°C, and
the presence or absence of temperature-resistant colonies
was scored. Many temperature-resistant recombinants were
obtained from SEY33-4 harboring pLB33-23, indicating that
the temperature-sensitive mutation likely lies 3' of the ClaI
site within the ORF. Various fragments containing this
region of the VPS33 gene were subcloned into the multicopy
vector pSEY18, and SEY33-4 transformants carrying these
plasmids were again scored for the frequency at which
temperature-resistant revertants arose. The results of this
analysis (data not shown) suggested that the temperature-
sensitive mutation mapped to the 250-bp region between the
SmaI site and the end of the ORF (Fig. 2C). The chromo-
somal mutation was recovered by transforming SEY33-4
with a replicating plasmid carrying VPS33 containing a
double-stranded gap between the SmaI and XbaI sites (33).
Sequencing of the SmaI-XbaI fragment from the rescued
plasmid revealed that a single base pair change within the
ORF, resulting in a leucine-to-proline change at residue 646,
was responsible for the temperature sensitivity. The pre-
dicted amino acid sequences of the wt VPS33 gene product
and the mutant Vps33p carrying the Leu-646 -- Pro altera-
tion were subjected to Chou-Fasman analysis (5). The pres-
ence of proline at position 646 is predicted to cause a
structural change in the VPS33 gene product, inserting a turn
in a region that is expected to form a random coil in the wt
protein.
The nature of the temperature sensitivity was examined by
retransforming various wt and vps33 strains with the vps33
gene carrying the rescued temperature-sensitive mutation on
single and multicopy vectors. Transformation of SEY33-4
with a second copy of the temperature sensitive mutant
allele resulted in a strain which grew slightly better at 37°C
than did the original mutant. A null mutant carrying the
vps334 mutant allele on a single-copy vector had a growth
rate comparable to that of the original mutant allele. Both
mutants exhibited wt growth at 37°C when the temperature-
sensitive allele was present on a multicopy vector. Transfor-
mation of the wt strain SEY6210 with either the single-copy
or the multicopy construction did not affect its ability to
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FIG. 8. Mother and bud vacuole staining in SEY33-4. SEY33-4 was grown in YPD at 25°C (A and B) and shifted to 37°C for 2 h (C and
D), 4 h (E and F), or 6 h (G to J) before harvesting. Also shown for comparison is the parental strain SEY6210 grown at 25°C (K) and shifted
to 37°C for 6 h (L). Cells were stained with FITC as described in Materials and Methods and observed by using Nomarski (left) or fluorescence
(right) optics. The number of buds exhibiting vacuole fluorescence was quantitated and expressed as a percentage of the total number of large
budded cells (n). Cells were grown at 25°C, incubated at 37°C for the indicated lengths of time, and stained with FITC as described above.
Bar, 10 ,Lm.
grow at 37°C (Fig. 9A). Thus, the mutant allele vps334(Ts) is
recessive to the wt allele even when overproduced. Further-
more, strains carrying the vps334 mutant allele appeared to
exhibit a dosage-dependent growth phenotype; overexpres-
sion of the mutant allele resulted in complementation of the
temperature-sensitive defect of the null mutant or SEY33-4.
However, although the strains carrying multiple copies of
vps334 were temperature resistant, they still exhibited a
partial Vps- phenotype. Immunoprecipitation experiments
indicated that 15% of the CPY accumulated in the precursor
form in SEY33-4 carrying the temperature-sensitive allele on
a multicopy plasmid (Fig. 9B). Together, our observations
suggest that the vps334 mutant allele encodes a partially
functional protein and that multiple copies of this protein can
compensate for its diminished activity. The partial function
of this Vps33-4p is unlikely to be a result of inactivation of
the 45 aa following the changed residue, since a 3' truncation
of the VPS33 gene, lacking the coding sequence for the
carboxy-terminal 56 aa, is unable to complement a vps33 null
mutation (data not shown).
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proCPY- 4 _
mCPY- _ _ _
FIG. 9. Rescue of the SEY33-4 phenotypic defe
pression of the mutant allele. (A) The indicatec
streaked on YPD solid medium and incubated at
Parental strain SEY6210; 2, SEY33-4; 3, SEY33-
plasmid pLB33-161 [vps33-4(Ts) allele on a single-c
SEY33-4 carrying the plasmid pLB33-271 [vps334(
multicopy vector]; 5, SEY6210 carrying pLB33-271.
were labeled and chased at 25°C (lanes 1 to 5) or 37
subjected to immunoprecipitation with CPY-speci
described in the legend to Fig. 5. Lanes 1 to 5 coni
listed above; for lane 6, SEY33-4 was grown at 25C
37°C for 5 h before radioactive labeling. Wild-type c
labeled under these conditions contain CPY excl
mature form (data not shown). The migration positio
(proCPY) and mature (mCPY) forms are shown.
DISCUSSION
VPS33, a gene required for vacuole proteil
normal vacuole formation, has been cloned an
Disruption of VPS33 leads to a temperature-sen
phenotype (Fig. 1), indicating that the gene is
growth only at elevated temperatures. At th
temperature, the null mutants are extremely
vacuolar protein processing and sorting (Fig. 5)
structure resembling a wt vacuole. These ph
comparable to those exhibited by most of the (
mutants, implying that many of the originally is
may be null (complete loss of function) ml
temperature sensitivity of the null mutants lik
requirement at 37°C for one or more vacuolar i
cannot be provided by whatever vacuole remna
these mutant cells.
The phenotypes exhibited by vps33 muta
those of the recently described mutant slpl (17)
was originally selected for its sensitivity to lysii
contains smaller than normal vacuolar pools o
nine, and histidine and is characterized by pi
fects, including lowered activities of soluble
zymes such as CPY and proteinase A and
morphology in which many small vesicles
vacuoles are observed. Complementation anal
that the slpl and vps33 mutants define a single
tation group (L. Banta, S. Emr, Y. Wada, an(
unpublished observations). Comparison of t}
maps and sequences of our VPS33 clone and
cloned SLPI gene (52) has demonstrated that t
are identical.
Antibodies raised against a TrpE-Vps33 fusion protein
recognize a relatively rare protein in yeast cells (<0.01% of
cell protein) of -75 kDa (Fig. 6). In cell fractionation
experiments, Vps33p behaves as a soluble cytoplasmic pro-
tein under a variety of lysis conditions (Fig. 7). The hydro-
1- s philic nature of the predicted amino acid sequence and the
apparent lack of N-linked glycosylation (Fig. 6) are consis-
tent with a cytoplasmic location for Vps33p.
The predicted amino acid sequence of Vps33p possesses
two regions of similarity with a number of ATPases and
_~ 4 ATP-binding proteins (Fig. 4). Several studies suggest that
these domains are directly involved in nucleotide binding or
enzyme function. The conserved lysine residue in adenylate
6 kinase, marked with an asterisk in Fig. 4, Domain A, has
been shown by affinity labeling and other experiments to
-69kd interact with ATP (7, 12, 51), and mutagenesis of the
- -61kd corresponding lysine in the E. coli ATPase a or i subunitimpaired apparent ATP-binding and catalytic activity (34,
39). A truncated form of VPS33, in which the coding
cts by overex- sequence for aa 636 to 691 (including the second region ofc
strains were ATP-binding protein homology) has been deleted, is unable
25 or 37°C. 1, to complement the temperature-sensitive or class C defects
4 carrying the associated with a vps33 null mutation. This observation is
opy vector]; 4, consistent with the idea that the region of sequence similar-
,Ts) allele on a ity between Vps33p and the family of ATP-binding proteins(B) Whole cells is functionally significant. A second class C vps mutant,iC (lane 6) and vpslI, falls into the same complementation group as the
Lain the strains mutant endi (8, 40). The ENDI gene has been cloned and
- and shifted to sequenced (8). This gene also shares sequence similarity
ells grown and with VPS33 and the family of ATP-binding protein genes
lusively in the throughout the two conserved domains. This observation
Ins of precursor raises the interesting possibility that ATP binding (and
perhaps ATP hydrolysis) plays a role in vacuolar protein
sorting and vacuole biogenesis. Further experiments, such
as ATP-binding studies and affinity labeling, will be neces-
sary to determine whether Vps33p does indeed bind ATP.
n sorting and One vps33 mutant strain, SEY33-4, exhibits a particularly
Id sequenced. interesting temperature-conditional defect in vacuolar pro-
isitive growth tein sorting and vacuole inheritance. At the permissive
;essential for temperature, this temperature-sensitive strain mislocalizes
te permissive 40% of the CPY but contains vacuoles that are apparently
defective in normal by a number of criteria. These vacuoles exhibit wt
and lack any staining with a variety of dyes, including quinacrine, a
tenotypes are compound that accumulates in vacuoles in a pH-dependent
)riginal vps33 manner (2, 54; L. Banta, unpublished observations). Unlike
iolated alleles the more defective class C strains, SEY33-4 does not mislo-
atations. The calize the vacuolar membrane enzyme a-mannosidase to the
,ely reflects a cell surface and is able to process 60% of the CPY to the
functions that mature form, indicating that the vacuoles in these cells are
ints remain in able to function as acceptor compartments for at least some
vacuolar proteins. Upon incubation of SEY33-4 at 37°C,
Lnts resemble budding cells appear to lack vacuole staining selectively in
1. This mutant the bud (Fig. 8) and the vacuolar protein processing defect is
ne. The strain exacerbated (Fig. 9). The temperature-sensitive defect in
iflysine, argi- this strain is due to a single base pair substitution which
leiotropic de- results in a leucine-to-proline change at position 646 in the
vacuolar en- VPS33 gene product. This mutation is predicted to cause a
an aberrant structural change in the carboxy terminus of the protein.
but no large The bud vacuole defect and increase in protein missorting
Iysis revealed observed in SEY33-4 at the nonpermissive temperature
complemen- suggest a number of possible roles for the wt Vps33p in
d Y. Anraku, vacuole biogenesis. For example, Vps33p may be required
he restriction for (i) vacuole segregation to the bud during cell division
the recently (55), (ii) maintenance of normal vacuolar structure, or (iii)
the two genes sorting and delivery of vacuolar proteins between the Golgi
and the vacuole. For the following reasons, we favor a model
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in which Vps33p acts primarily in Golgi-to-vacuolar protein
transport. The observation that Vps33p fractionates as a
cytosolic protein suggests that this protein is not a structural
component of the vacuole itself. In addition, the existence of
SEY33-4 and a second vps33 strain, SEY33-5, that mislocal-
ize CPY yet contain apparently normal vacuoles at 25°C is
inconsistent with a structural function for Vps33p in main-
taining vacuole integrity. A primary role for Vps33p in
vacuole inheritance also seems unlikely, given that SEY33-4
and SEY33-5 exhibit apparently normal vacuole segregation
patterns during cell division at the permissive temperature.
These observations suggest that the primary defect in these
mutants lies in Golgi-to-vacuole trafficking. If Vps33p were
directly involved in vacuole inheritance or vacuolar struc-
ture, mutants that clearly affect vacuole protein localization
would also be expected to exhibit morphological abnormal-
ities in the vacuole.
The simplest explanation for the extreme abnormalities in
vacuole morphology exhibited by most of the vps33 mutants
is that as a consequence of a primary defect in Golgi-to-
vacuole protein transport, proteins necessary for vacuolar
inheritance or structural stability are mislocalized. In strong
vps33 mutants, which exhibit partial missorting of a vacuolar
membrane component as well as almost completely aberrant
targeting of soluble hydrolases, vacuole assembly is severely
impaired. The less defective mutant SEY33-4 appears to
contain a partially functional Vps33p. The residual activity is
sufficient to permit some Golgi-to-vacuole protein transport
and thus the formation of nearly normal vacuoles. The lack
of a vacuole in the bud at 37°C may reflect a more complete
loss of function if, for example, the mutant protein is less
stable at high temperatures. We cannot exclude, however,
the possibility that the VPS33 gene product is bifunctional,
with roles in both vacuole protein targeting and vacuole
maintenance or segregation to emerging buds. In this sce-
nario, the protein encoded by the vps334 allele might be
defective in only the former function at 250C but both
functions at 37°C.
A possible role for Vps33p in Golgi-to-vacuole sorting is
suggested by a recent observation that the protein is phos-
phorylated in vivo (P. Herman, J. Stack, and S. Emr,
unpublished observations). Perhaps Vps33p undergoes a
cycle of phosphorylation-dephosphorylation, which in turn
regulates its activity in promoting Golgi-to-vacuole protein
transport. Since this transport is assumed to be vesicle
mediated, the VPS33 gene product could act at the level of
vesicle formation, transport, or fusion with the target or-
ganelle. The accumulation of many small vesicles in vps33
mutant cells (2) suggests that the defect in these strains may
occur after vesicle formation. Using the probes developed in
this study in conjunction with an in vitro assay for protein
transport from the Golgi to the vacuole (T. A. Vida, T. R.
Graham, and S. D. Emr, submitted for publication), we hope
to determine the step(s) at which Vps33p acts as well as the
significance of the observed phosphorylation.
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